Andrew McIntosh
Concepts (552)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome-Wide Association Study | 107 | 2026 | 1537 | 7.120 |
Why?
| | Genetic Predisposition to Disease | 91 | 2026 | 2488 | 5.700 |
Why?
| | Bipolar Disorder | 32 | 2026 | 285 | 4.670 |
Why?
| | Schizophrenia | 46 | 2026 | 537 | 4.170 |
Why?
| | Multifactorial Inheritance | 40 | 2026 | 243 | 3.800 |
Why?
| | DNA Methylation | 41 | 2026 | 725 | 3.600 |
Why?
| | Depression | 38 | 2026 | 1575 | 3.570 |
Why?
| | Polymorphism, Single Nucleotide | 71 | 2026 | 2240 | 3.140 |
Why?
| | Biological Specimen Banks | 31 | 2025 | 137 | 2.810 |
Why?
| | United Kingdom | 50 | 2025 | 377 | 2.740 |
Why?
| | Scotland | 32 | 2026 | 54 | 2.270 |
Why?
| | Mental Disorders | 23 | 2026 | 1148 | 2.140 |
Why?
| | Brain | 48 | 2026 | 2991 | 2.070 |
Why?
| | Epigenesis, Genetic | 30 | 2025 | 712 | 1.670 |
Why?
| | White Matter | 12 | 2024 | 169 | 1.490 |
Why?
| | Phenotype | 38 | 2026 | 3206 | 1.470 |
Why?
| | Antidepressive Agents | 5 | 2025 | 235 | 1.460 |
Why?
| | Cohort Studies | 46 | 2026 | 6077 | 1.390 |
Why?
| | Prefrontal Cortex | 6 | 2020 | 339 | 1.350 |
Why?
| | Humans | 260 | 2026 | 146342 | 1.340 |
Why?
| | Brain Mapping | 13 | 2022 | 541 | 1.260 |
Why?
| | Magnetic Resonance Imaging | 40 | 2026 | 3926 | 1.230 |
Why?
| | Cognition | 18 | 2024 | 1292 | 1.190 |
Why?
| | Neuroimaging | 15 | 2022 | 307 | 1.170 |
Why?
| | Aging | 20 | 2025 | 1996 | 1.100 |
Why?
| | Epigenomics | 11 | 2025 | 124 | 1.090 |
Why?
| | Male | 150 | 2026 | 73396 | 1.080 |
Why?
| | Neuroticism | 6 | 2019 | 22 | 1.070 |
Why?
| | Middle Aged | 97 | 2026 | 36619 | 1.060 |
Why?
| | Female | 152 | 2026 | 79499 | 1.050 |
Why?
| | Mental Health | 7 | 2026 | 779 | 1.040 |
Why?
| | Adult | 104 | 2026 | 41087 | 0.970 |
Why?
| | Quantitative Trait Loci | 13 | 2026 | 388 | 0.970 |
Why?
| | Mendelian Randomization Analysis | 9 | 2025 | 68 | 0.930 |
Why?
| | Chronic Pain | 7 | 2021 | 304 | 0.920 |
Why?
| | Aged | 75 | 2026 | 26432 | 0.890 |
Why?
| | Alcohol Drinking | 10 | 2025 | 850 | 0.880 |
Why?
| | Gene-Environment Interaction | 6 | 2026 | 190 | 0.870 |
Why?
| | Psychotic Disorders | 8 | 2021 | 188 | 0.850 |
Why?
| | Alcoholism | 11 | 2024 | 830 | 0.850 |
Why?
| | Genetic Loci | 13 | 2026 | 273 | 0.840 |
Why?
| | Self Report | 9 | 2025 | 870 | 0.830 |
Why?
| | Risk Factors | 41 | 2025 | 10921 | 0.820 |
Why?
| | Depressive Disorder | 7 | 2026 | 361 | 0.810 |
Why?
| | Anxiety Disorders | 7 | 2026 | 354 | 0.790 |
Why?
| | Pharmacoepidemiology | 2 | 2019 | 24 | 0.730 |
Why?
| | Cerebral Cortex | 8 | 2021 | 485 | 0.720 |
Why?
| | Anxiety | 10 | 2026 | 1125 | 0.700 |
Why?
| | Pregnancy Proteins | 1 | 2021 | 36 | 0.690 |
Why?
| | Neurodevelopmental Disorders | 6 | 2025 | 239 | 0.690 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2023 | 145 | 0.680 |
Why?
| | Haplotypes | 4 | 2017 | 506 | 0.680 |
Why?
| | Family Health | 5 | 2024 | 194 | 0.680 |
Why?
| | Gray Matter | 4 | 2024 | 96 | 0.670 |
Why?
| | Cytochrome P-450 CYP2C19 | 3 | 2026 | 29 | 0.660 |
Why?
| | Antigen Presentation | 1 | 2022 | 209 | 0.650 |
Why?
| | CpG Islands | 13 | 2026 | 175 | 0.640 |
Why?
| | Intelligence | 5 | 2022 | 119 | 0.640 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 5 | 2021 | 422 | 0.630 |
Why?
| | Transcranial Magnetic Stimulation | 2 | 2015 | 69 | 0.630 |
Why?
| | Health Surveys | 2 | 2020 | 511 | 0.630 |
Why?
| | Brain Concussion | 7 | 2022 | 660 | 0.620 |
Why?
| | Case-Control Studies | 26 | 2026 | 3647 | 0.610 |
Why?
| | Nerve Tissue Proteins | 5 | 2021 | 597 | 0.600 |
Why?
| | Electronic Mail | 1 | 2020 | 63 | 0.600 |
Why?
| | Mood Disorders | 6 | 2021 | 130 | 0.600 |
Why?
| | Sex Characteristics | 7 | 2022 | 801 | 0.580 |
Why?
| | Smoking | 3 | 2021 | 1486 | 0.550 |
Why?
| | Young Adult | 35 | 2026 | 14330 | 0.540 |
Why?
| | Drug Utilization | 1 | 2019 | 171 | 0.530 |
Why?
| | Age of Onset | 5 | 2021 | 558 | 0.530 |
Why?
| | Connectome | 5 | 2024 | 100 | 0.520 |
Why?
| | Chromosomes, Human, Pair 6 | 1 | 2017 | 51 | 0.520 |
Why?
| | Risk Assessment | 8 | 2024 | 3712 | 0.510 |
Why?
| | Neurodegenerative Diseases | 4 | 2025 | 147 | 0.500 |
Why?
| | Biomarkers | 13 | 2025 | 4340 | 0.500 |
Why?
| | Adolescent | 38 | 2026 | 22557 | 0.500 |
Why?
| | Longitudinal Studies | 16 | 2026 | 3017 | 0.490 |
Why?
| | Nerve Net | 3 | 2024 | 286 | 0.490 |
Why?
| | HMGB Proteins | 1 | 2016 | 16 | 0.490 |
Why?
| | Genomics | 6 | 2025 | 853 | 0.490 |
Why?
| | Human Development | 3 | 2021 | 22 | 0.480 |
Why?
| | Diabetes Mellitus, Type 2 | 8 | 2024 | 2623 | 0.480 |
Why?
| | Health Status | 5 | 2026 | 827 | 0.480 |
Why?
| | Prescription Drugs | 1 | 2017 | 110 | 0.470 |
Why?
| | Genetic Variation | 8 | 2021 | 996 | 0.470 |
Why?
| | Image Processing, Computer-Assisted | 10 | 2020 | 778 | 0.460 |
Why?
| | Cognition Disorders | 6 | 2017 | 559 | 0.460 |
Why?
| | Nerve Growth Factors | 1 | 2016 | 79 | 0.460 |
Why?
| | Synaptic Transmission | 1 | 2018 | 294 | 0.460 |
Why?
| | Environment | 2 | 2016 | 299 | 0.450 |
Why?
| | Data Mining | 1 | 2016 | 113 | 0.450 |
Why?
| | Memory, Short-Term | 2 | 2017 | 276 | 0.440 |
Why?
| | Drug Monitoring | 1 | 2019 | 399 | 0.440 |
Why?
| | Schizophrenic Psychology | 6 | 2019 | 121 | 0.430 |
Why?
| | Diffusion Tensor Imaging | 8 | 2020 | 83 | 0.430 |
Why?
| | Autism Spectrum Disorder | 1 | 2020 | 406 | 0.430 |
Why?
| | Transcriptome | 5 | 2026 | 1068 | 0.420 |
Why?
| | Head Protective Devices | 7 | 2022 | 30 | 0.420 |
Why?
| | Head | 6 | 2022 | 125 | 0.420 |
Why?
| | Life Change Events | 4 | 2024 | 144 | 0.420 |
Why?
| | Genotype | 12 | 2026 | 1879 | 0.410 |
Why?
| | Proteome | 3 | 2024 | 520 | 0.400 |
Why?
| | Tumor Suppressor Proteins | 1 | 2016 | 315 | 0.400 |
Why?
| | Resilience, Psychological | 1 | 2016 | 141 | 0.390 |
Why?
| | Accelerometry | 3 | 2020 | 124 | 0.390 |
Why?
| | Aged, 80 and over | 17 | 2025 | 8391 | 0.390 |
Why?
| | Interleukin-6 | 3 | 2025 | 784 | 0.390 |
Why?
| | Athletic Injuries | 4 | 2024 | 575 | 0.390 |
Why?
| | Global Health | 1 | 2016 | 403 | 0.380 |
Why?
| | Apolipoprotein E4 | 3 | 2021 | 47 | 0.380 |
Why?
| | Calcium Channels | 1 | 2014 | 157 | 0.380 |
Why?
| | Chromosome Mapping | 5 | 2025 | 508 | 0.370 |
Why?
| | Genome, Human | 4 | 2024 | 431 | 0.370 |
Why?
| | Genetic Association Studies | 6 | 2020 | 379 | 0.360 |
Why?
| | Linkage Disequilibrium | 8 | 2020 | 260 | 0.360 |
Why?
| | Databases, Factual | 7 | 2020 | 1493 | 0.360 |
Why?
| | Pedigree | 3 | 2019 | 512 | 0.350 |
Why?
| | Gene Expression Regulation | 8 | 2026 | 2599 | 0.350 |
Why?
| | Comorbidity | 7 | 2024 | 1665 | 0.340 |
Why?
| | Craniocerebral Trauma | 2 | 2024 | 173 | 0.340 |
Why?
| | Internal Capsule | 1 | 2011 | 10 | 0.330 |
Why?
| | Temperament | 1 | 2011 | 40 | 0.330 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2011 | 47 | 0.330 |
Why?
| | Suicide, Attempted | 4 | 2025 | 391 | 0.320 |
Why?
| | Aging, Premature | 2 | 2022 | 18 | 0.320 |
Why?
| | Cross-Sectional Studies | 13 | 2025 | 5899 | 0.320 |
Why?
| | Insulin Resistance | 1 | 2019 | 1247 | 0.320 |
Why?
| | Signal Transduction | 5 | 2026 | 5246 | 0.310 |
Why?
| | Sports | 3 | 2022 | 217 | 0.310 |
Why?
| | Cardiovascular Diseases | 5 | 2024 | 2219 | 0.310 |
Why?
| | Educational Status | 3 | 2021 | 466 | 0.310 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2019 | 1763 | 0.300 |
Why?
| | Marijuana Abuse | 3 | 2020 | 217 | 0.300 |
Why?
| | Wearable Electronic Devices | 2 | 2022 | 75 | 0.300 |
Why?
| | Risk | 9 | 2020 | 920 | 0.290 |
Why?
| | Social Class | 2 | 2025 | 260 | 0.290 |
Why?
| | Acceleration | 4 | 2022 | 36 | 0.290 |
Why?
| | Patient Selection | 2 | 2025 | 728 | 0.280 |
Why?
| | Prevalence | 7 | 2024 | 2861 | 0.280 |
Why?
| | Translocation, Genetic | 2 | 2019 | 127 | 0.270 |
Why?
| | Hallucinations | 2 | 2007 | 33 | 0.270 |
Why?
| | Inflammation | 5 | 2025 | 2919 | 0.270 |
Why?
| | Australia | 7 | 2025 | 291 | 0.270 |
Why?
| | Saliva | 3 | 2025 | 256 | 0.270 |
Why?
| | Psychiatric Status Rating Scales | 6 | 2018 | 522 | 0.270 |
Why?
| | Genetic Markers | 3 | 2018 | 340 | 0.270 |
Why?
| | Cognitive Dysfunction | 3 | 2025 | 481 | 0.270 |
Why?
| | Logistic Models | 5 | 2024 | 2126 | 0.260 |
Why?
| | Neural Pathways | 6 | 2022 | 319 | 0.260 |
Why?
| | Anisotropy | 5 | 2017 | 77 | 0.260 |
Why?
| | Child | 17 | 2026 | 22693 | 0.260 |
Why?
| | Netrin-1 | 2 | 2018 | 17 | 0.260 |
Why?
| | Gyrus Cinguli | 2 | 2019 | 98 | 0.260 |
Why?
| | ErbB Receptors | 1 | 2011 | 636 | 0.260 |
Why?
| | Diagnostic Self Evaluation | 2 | 2017 | 24 | 0.250 |
Why?
| | Affect | 3 | 2020 | 318 | 0.250 |
Why?
| | Cause of Death | 3 | 2020 | 456 | 0.240 |
Why?
| | Alleles | 5 | 2022 | 907 | 0.240 |
Why?
| | Family | 4 | 2019 | 690 | 0.240 |
Why?
| | DEAD-box RNA Helicases | 1 | 2026 | 90 | 0.230 |
Why?
| | Off-Road Motor Vehicles | 1 | 2025 | 4 | 0.230 |
Why?
| | Accidents, Occupational | 1 | 2025 | 18 | 0.220 |
Why?
| | Microvessels | 1 | 2026 | 98 | 0.220 |
Why?
| | Image Interpretation, Computer-Assisted | 3 | 2020 | 295 | 0.220 |
Why?
| | Agriculture | 1 | 2025 | 94 | 0.210 |
Why?
| | Chronic Traumatic Encephalopathy | 1 | 2024 | 18 | 0.210 |
Why?
| | Body Mass Index | 4 | 2021 | 2458 | 0.210 |
Why?
| | Adaptor Proteins, Signal Transducing | 3 | 2022 | 429 | 0.210 |
Why?
| | Cytochrome P-450 CYP2D6 | 1 | 2024 | 33 | 0.210 |
Why?
| | Growth Differentiation Factor 15 | 1 | 2024 | 44 | 0.210 |
Why?
| | Hippocampus | 5 | 2021 | 989 | 0.210 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2026 | 195 | 0.210 |
Why?
| | Substance-Related Disorders | 3 | 2021 | 1100 | 0.200 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2024 | 110 | 0.200 |
Why?
| | Pain | 2 | 2019 | 790 | 0.200 |
Why?
| | Birth Weight | 3 | 2021 | 521 | 0.200 |
Why?
| | Neuropsychological Tests | 6 | 2018 | 1149 | 0.200 |
Why?
| | Vision Disparity | 1 | 2003 | 4 | 0.200 |
Why?
| | Photic Stimulation | 2 | 2009 | 265 | 0.200 |
Why?
| | Linear Models | 6 | 2019 | 857 | 0.190 |
Why?
| | Safety | 1 | 2025 | 347 | 0.190 |
Why?
| | Urban Population | 1 | 2026 | 497 | 0.190 |
Why?
| | DNA Copy Number Variations | 3 | 2021 | 192 | 0.190 |
Why?
| | Internet | 2 | 2025 | 660 | 0.190 |
Why?
| | Quantitative Trait, Heritable | 3 | 2021 | 119 | 0.190 |
Why?
| | Genomic Imprinting | 2 | 2021 | 28 | 0.190 |
Why?
| | Alcohol Dehydrogenase | 2 | 2019 | 21 | 0.190 |
Why?
| | Fatty Acid Desaturases | 1 | 2023 | 32 | 0.180 |
Why?
| | Bulimia | 1 | 2022 | 35 | 0.180 |
Why?
| | Fear | 1 | 2026 | 373 | 0.180 |
Why?
| | Binge-Eating Disorder | 1 | 2022 | 31 | 0.180 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2023 | 97 | 0.180 |
Why?
| | Telomere Shortening | 1 | 2022 | 20 | 0.180 |
Why?
| | Docosahexaenoic Acids | 1 | 2023 | 91 | 0.180 |
Why?
| | Corpus Striatum | 2 | 2021 | 181 | 0.180 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2020 | 928 | 0.180 |
Why?
| | Cerebral Small Vessel Diseases | 1 | 2021 | 6 | 0.180 |
Why?
| | Amygdala | 3 | 2021 | 194 | 0.180 |
Why?
| | Genes | 2 | 2019 | 215 | 0.170 |
Why?
| | Depression, Postpartum | 1 | 2023 | 117 | 0.170 |
Why?
| | Netherlands | 1 | 2021 | 85 | 0.170 |
Why?
| | Surveys and Questionnaires | 7 | 2025 | 6073 | 0.170 |
Why?
| | Activities of Daily Living | 1 | 2025 | 442 | 0.170 |
Why?
| | Sirtuin 1 | 1 | 2021 | 35 | 0.170 |
Why?
| | Histone Demethylases | 1 | 2021 | 39 | 0.170 |
Why?
| | Dioxygenases | 1 | 2021 | 36 | 0.170 |
Why?
| | Sex Factors | 5 | 2025 | 2107 | 0.170 |
Why?
| | Rural Population | 1 | 2026 | 677 | 0.170 |
Why?
| | Apolipoprotein E2 | 1 | 2021 | 4 | 0.170 |
Why?
| | Self-Injurious Behavior | 1 | 2022 | 129 | 0.160 |
Why?
| | Socioeconomic Factors | 2 | 2024 | 1327 | 0.160 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2024 | 198 | 0.160 |
Why?
| | Diabetes Mellitus | 2 | 2022 | 1101 | 0.160 |
Why?
| | Thalamus | 2 | 2021 | 134 | 0.160 |
Why?
| | Biological Variation, Population | 1 | 2020 | 22 | 0.160 |
Why?
| | Income | 2 | 2025 | 206 | 0.160 |
Why?
| | Peptide Fragments | 1 | 2024 | 693 | 0.160 |
Why?
| | Immune System | 1 | 2021 | 181 | 0.160 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 2 | 2022 | 233 | 0.160 |
Why?
| | Shoulder Pain | 1 | 2020 | 37 | 0.160 |
Why?
| | Child Abuse | 1 | 2026 | 545 | 0.150 |
Why?
| | Neck Pain | 1 | 2020 | 35 | 0.150 |
Why?
| | Models, Theoretical | 2 | 2020 | 561 | 0.150 |
Why?
| | Biomechanical Phenomena | 5 | 2022 | 874 | 0.150 |
Why?
| | Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2020 | 36 | 0.150 |
Why?
| | Reward | 2 | 2020 | 242 | 0.150 |
Why?
| | Motor Neuron Disease | 1 | 2019 | 21 | 0.150 |
Why?
| | Growth Differentiation Factor 5 | 1 | 2019 | 4 | 0.150 |
Why?
| | Tobacco Smoking | 1 | 2019 | 29 | 0.150 |
Why?
| | Fibrillar Collagens | 1 | 2019 | 15 | 0.150 |
Why?
| | Genetic Pleiotropy | 1 | 2019 | 37 | 0.150 |
Why?
| | Cell Adhesion Molecules, Neuronal | 1 | 2019 | 43 | 0.150 |
Why?
| | Exome | 4 | 2022 | 233 | 0.150 |
Why?
| | Glucocorticoids | 2 | 2021 | 536 | 0.150 |
Why?
| | Frontotemporal Dementia | 1 | 2019 | 56 | 0.140 |
Why?
| | Mortality, Premature | 1 | 2019 | 14 | 0.140 |
Why?
| | Forkhead Transcription Factors | 1 | 2020 | 209 | 0.140 |
Why?
| | Psychological Trauma | 1 | 2020 | 58 | 0.140 |
Why?
| | Intellectual Disability | 2 | 2018 | 183 | 0.140 |
Why?
| | Life Style | 4 | 2024 | 496 | 0.140 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 449 | 0.140 |
Why?
| | Chromosomes, Human, Pair 16 | 1 | 2018 | 36 | 0.140 |
Why?
| | Mortality | 2 | 2018 | 375 | 0.140 |
Why?
| | Soccer | 1 | 2019 | 40 | 0.140 |
Why?
| | Organ Size | 4 | 2025 | 465 | 0.140 |
Why?
| | Myocardial Ischemia | 1 | 2020 | 286 | 0.140 |
Why?
| | Cerebrovascular Disorders | 1 | 2019 | 103 | 0.140 |
Why?
| | Incidence | 3 | 2021 | 2936 | 0.140 |
Why?
| | Suicide | 1 | 2025 | 647 | 0.140 |
Why?
| | Prospective Studies | 10 | 2022 | 8123 | 0.140 |
Why?
| | Genes, Lethal | 1 | 2018 | 29 | 0.140 |
Why?
| | Diffusion Magnetic Resonance Imaging | 3 | 2020 | 158 | 0.130 |
Why?
| | Longevity | 1 | 2019 | 179 | 0.130 |
Why?
| | Machine Learning | 2 | 2022 | 594 | 0.130 |
Why?
| | RNA, Long Noncoding | 1 | 2020 | 174 | 0.130 |
Why?
| | Cost of Illness | 1 | 2020 | 323 | 0.130 |
Why?
| | Regression Analysis | 4 | 2019 | 999 | 0.130 |
Why?
| | Memory | 4 | 2017 | 298 | 0.130 |
Why?
| | Premature Birth | 1 | 2022 | 390 | 0.130 |
Why?
| | Registries | 3 | 2015 | 2400 | 0.130 |
Why?
| | Feeding and Eating Disorders | 1 | 2020 | 162 | 0.130 |
Why?
| | Myelin Sheath | 1 | 2019 | 166 | 0.130 |
Why?
| | Physical Fitness | 1 | 2019 | 209 | 0.130 |
Why?
| | Drosophila melanogaster | 1 | 2019 | 237 | 0.130 |
Why?
| | Program Development | 1 | 2019 | 371 | 0.130 |
Why?
| | Synapses | 2 | 2018 | 448 | 0.130 |
Why?
| | Substantia Nigra | 1 | 2017 | 64 | 0.130 |
Why?
| | International Classification of Diseases | 1 | 2018 | 142 | 0.130 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2019 | 266 | 0.130 |
Why?
| | Molecular Epidemiology | 1 | 2017 | 74 | 0.130 |
Why?
| | Oligodendroglia | 1 | 2019 | 198 | 0.120 |
Why?
| | Ireland | 1 | 2016 | 33 | 0.120 |
Why?
| | Choice Behavior | 1 | 2018 | 179 | 0.120 |
Why?
| | Ventral Tegmental Area | 1 | 2017 | 61 | 0.120 |
Why?
| | Headache | 1 | 2018 | 150 | 0.120 |
Why?
| | Mechanotransduction, Cellular | 1 | 2018 | 121 | 0.120 |
Why?
| | Angina Pectoris | 1 | 2017 | 76 | 0.120 |
Why?
| | Age Distribution | 1 | 2017 | 399 | 0.120 |
Why?
| | Coronary Artery Disease | 3 | 2020 | 751 | 0.120 |
Why?
| | Interleukin-1 Receptor Accessory Protein | 1 | 2016 | 10 | 0.120 |
Why?
| | Functional Neuroimaging | 2 | 2017 | 61 | 0.120 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 28 | 0.120 |
Why?
| | Age Factors | 6 | 2021 | 3347 | 0.120 |
Why?
| | Multifactor Dimensionality Reduction | 1 | 2016 | 3 | 0.120 |
Why?
| | Metabolic Syndrome | 1 | 2020 | 364 | 0.120 |
Why?
| | C-Reactive Protein | 1 | 2018 | 429 | 0.120 |
Why?
| | Athletes | 2 | 2017 | 432 | 0.120 |
Why?
| | Birth Order | 1 | 2016 | 15 | 0.120 |
Why?
| | Character | 1 | 2016 | 3 | 0.120 |
Why?
| | Temporal Lobe | 4 | 2009 | 112 | 0.120 |
Why?
| | Cannabis | 1 | 2003 | 521 | 0.120 |
Why?
| | Maternal Age | 1 | 2016 | 129 | 0.120 |
Why?
| | Mental Health Services | 1 | 2021 | 450 | 0.110 |
Why?
| | Facial Expression | 1 | 2016 | 66 | 0.110 |
Why?
| | Risk-Taking | 1 | 2018 | 321 | 0.110 |
Why?
| | Selection, Genetic | 1 | 2018 | 269 | 0.110 |
Why?
| | Datasets as Topic | 3 | 2020 | 120 | 0.110 |
Why?
| | Genetic Load | 1 | 2015 | 3 | 0.110 |
Why?
| | Mutation | 3 | 2022 | 4093 | 0.110 |
Why?
| | Genetic Phenomena | 1 | 2015 | 7 | 0.110 |
Why?
| | Knee Joint | 1 | 2019 | 453 | 0.110 |
Why?
| | Drug Prescriptions | 1 | 2017 | 314 | 0.110 |
Why?
| | Alzheimer Disease | 2 | 2025 | 641 | 0.110 |
Why?
| | Borderline Personality Disorder | 1 | 2015 | 15 | 0.110 |
Why?
| | Gene Expression Profiling | 4 | 2026 | 1792 | 0.110 |
Why?
| | DNA | 1 | 2021 | 1421 | 0.110 |
Why?
| | NF-kappa B | 1 | 2018 | 674 | 0.110 |
Why?
| | Social Environment | 1 | 2016 | 246 | 0.110 |
Why?
| | Smoking Cessation | 1 | 2018 | 442 | 0.110 |
Why?
| | Reproducibility of Results | 3 | 2019 | 3416 | 0.100 |
Why?
| | Carrier Proteins | 1 | 2018 | 728 | 0.100 |
Why?
| | DNA-Binding Proteins | 1 | 2021 | 1468 | 0.100 |
Why?
| | Self Concept | 1 | 2016 | 257 | 0.100 |
Why?
| | Circadian Rhythm | 1 | 2018 | 515 | 0.100 |
Why?
| | Reaction Time | 4 | 2018 | 438 | 0.100 |
Why?
| | Treatment Outcome | 4 | 2025 | 11821 | 0.100 |
Why?
| | Disease Susceptibility | 2 | 2018 | 339 | 0.100 |
Why?
| | Cerebral Ventricles | 2 | 2011 | 56 | 0.100 |
Why?
| | Phobic Disorders | 2 | 2026 | 36 | 0.100 |
Why?
| | Kaplan-Meier Estimate | 1 | 2015 | 970 | 0.090 |
Why?
| | Chromosomes, Human, Pair 12 | 1 | 2012 | 22 | 0.090 |
Why?
| | Models, Statistical | 1 | 2016 | 669 | 0.090 |
Why?
| | Databases, Bibliographic | 1 | 2012 | 30 | 0.090 |
Why?
| | Echo-Planar Imaging | 1 | 2011 | 24 | 0.080 |
Why?
| | Emotions | 2 | 2022 | 559 | 0.080 |
Why?
| | Hypertension | 2 | 2017 | 1272 | 0.080 |
Why?
| | Principal Component Analysis | 3 | 2018 | 192 | 0.080 |
Why?
| | Receptor, ErbB-4 | 1 | 2011 | 19 | 0.080 |
Why?
| | Pregnancy | 5 | 2026 | 7230 | 0.080 |
Why?
| | Analysis of Variance | 2 | 2011 | 1298 | 0.080 |
Why?
| | Severity of Illness Index | 3 | 2026 | 2921 | 0.080 |
Why?
| | Personality Inventory | 1 | 2011 | 132 | 0.080 |
Why?
| | Mental Status and Dementia Tests | 2 | 2024 | 28 | 0.080 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 2 | 2018 | 224 | 0.080 |
Why?
| | Imaging, Three-Dimensional | 2 | 2017 | 582 | 0.080 |
Why?
| | Functional Laterality | 1 | 2011 | 242 | 0.080 |
Why?
| | Chromosomes, Human | 2 | 2021 | 45 | 0.080 |
Why?
| | DiGeorge Syndrome | 1 | 2009 | 32 | 0.070 |
Why?
| | Factor Analysis, Statistical | 2 | 2021 | 298 | 0.070 |
Why?
| | Bayes Theorem | 2 | 2024 | 426 | 0.070 |
Why?
| | Atrophy | 2 | 2025 | 199 | 0.070 |
Why?
| | Medical History Taking | 2 | 2021 | 117 | 0.070 |
Why?
| | Skull | 2 | 2015 | 162 | 0.070 |
Why?
| | Meta-Analysis as Topic | 3 | 2015 | 173 | 0.070 |
Why?
| | Gene Ontology | 2 | 2021 | 55 | 0.070 |
Why?
| | Predictive Value of Tests | 3 | 2023 | 2113 | 0.070 |
Why?
| | Research Design | 2 | 2026 | 1143 | 0.070 |
Why?
| | Databases, Genetic | 2 | 2020 | 239 | 0.070 |
Why?
| | Video Recording | 2 | 2020 | 219 | 0.070 |
Why?
| | Transcription Factors | 1 | 2016 | 1730 | 0.070 |
Why?
| | Delusions | 1 | 2007 | 11 | 0.070 |
Why?
| | Disease Progression | 2 | 2017 | 2867 | 0.070 |
Why?
| | Rest | 2 | 2018 | 126 | 0.070 |
Why?
| | Stress, Psychological | 1 | 2016 | 1171 | 0.070 |
Why?
| | Heterozygote | 2 | 2021 | 311 | 0.060 |
Why?
| | Quality Assurance, Health Care | 1 | 2009 | 349 | 0.060 |
Why?
| | Europe | 2 | 2018 | 421 | 0.060 |
Why?
| | Endophenotypes | 2 | 2017 | 37 | 0.060 |
Why?
| | Dementia | 2 | 2024 | 324 | 0.060 |
Why?
| | Agoraphobia | 1 | 2026 | 9 | 0.060 |
Why?
| | Malawi | 1 | 2026 | 58 | 0.060 |
Why?
| | Phobia, Social | 1 | 2026 | 12 | 0.060 |
Why?
| | Arthritis, Rheumatoid | 1 | 2015 | 1185 | 0.060 |
Why?
| | Panic Disorder | 1 | 2026 | 24 | 0.060 |
Why?
| | Behavior | 1 | 2006 | 90 | 0.060 |
Why?
| | Proteomics | 2 | 2024 | 1203 | 0.060 |
Why?
| | Neoplasms | 1 | 2022 | 2954 | 0.060 |
Why?
| | Neuronal Plasticity | 2 | 2019 | 312 | 0.060 |
Why?
| | Induced Pluripotent Stem Cells | 2 | 2019 | 269 | 0.060 |
Why?
| | Inheritance Patterns | 2 | 2018 | 49 | 0.060 |
Why?
| | Gene Frequency | 2 | 2018 | 496 | 0.060 |
Why?
| | Utah | 1 | 2025 | 82 | 0.060 |
Why?
| | Child, Preschool | 4 | 2022 | 11913 | 0.060 |
Why?
| | Hand Strength | 1 | 2026 | 149 | 0.060 |
Why?
| | Proportional Hazards Models | 2 | 2019 | 1331 | 0.060 |
Why?
| | Paroxetine | 1 | 2025 | 8 | 0.060 |
Why?
| | Personal Protective Equipment | 1 | 2025 | 59 | 0.050 |
Why?
| | Sweden | 1 | 2025 | 114 | 0.050 |
Why?
| | Sertraline | 1 | 2025 | 26 | 0.050 |
Why?
| | Basal Ganglia | 2 | 2020 | 60 | 0.050 |
Why?
| | Citalopram | 1 | 2025 | 33 | 0.050 |
Why?
| | Computational Biology | 2 | 2020 | 678 | 0.050 |
Why?
| | Autistic Disorder | 1 | 2007 | 216 | 0.050 |
Why?
| | Fluoxetine | 1 | 2025 | 56 | 0.050 |
Why?
| | Uganda | 1 | 2024 | 91 | 0.050 |
Why?
| | Cadherins | 1 | 2025 | 202 | 0.050 |
Why?
| | Canada | 1 | 2025 | 432 | 0.050 |
Why?
| | Causality | 1 | 2024 | 128 | 0.050 |
Why?
| | Retrospective Studies | 4 | 2025 | 17438 | 0.050 |
Why?
| | Gene Regulatory Networks | 1 | 2026 | 319 | 0.050 |
Why?
| | Models, Genetic | 1 | 2026 | 540 | 0.050 |
Why?
| | Troponin I | 1 | 2024 | 74 | 0.050 |
Why?
| | Gene Expression | 2 | 2018 | 1463 | 0.050 |
Why?
| | Stroke | 2 | 2024 | 1287 | 0.050 |
Why?
| | Mice | 4 | 2023 | 18297 | 0.050 |
Why?
| | Social Media | 1 | 2025 | 159 | 0.050 |
Why?
| | Happiness | 1 | 2022 | 21 | 0.050 |
Why?
| | Cost-Benefit Analysis | 1 | 2025 | 640 | 0.050 |
Why?
| | Protective Factors | 1 | 2022 | 97 | 0.050 |
Why?
| | Gender Identity | 1 | 2023 | 132 | 0.050 |
Why?
| | Diagnosis, Differential | 1 | 2026 | 1503 | 0.040 |
Why?
| | Molecular Biology | 1 | 2022 | 59 | 0.040 |
Why?
| | Disclosure | 1 | 2022 | 91 | 0.040 |
Why?
| | Caudate Nucleus | 2 | 2015 | 23 | 0.040 |
Why?
| | Cross-Over Studies | 1 | 2004 | 615 | 0.040 |
Why?
| | Bias | 1 | 2022 | 197 | 0.040 |
Why?
| | Cytoskeletal Proteins | 1 | 2022 | 146 | 0.040 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2021 | 64 | 0.040 |
Why?
| | Patient Health Questionnaire | 1 | 2021 | 43 | 0.040 |
Why?
| | Sulfurtransferases | 1 | 2021 | 10 | 0.040 |
Why?
| | A Kinase Anchor Proteins | 1 | 2022 | 75 | 0.040 |
Why?
| | Pilot Projects | 2 | 2020 | 1888 | 0.040 |
Why?
| | Africa | 1 | 2021 | 119 | 0.040 |
Why?
| | Animals | 5 | 2023 | 38107 | 0.040 |
Why?
| | Sensitivity and Specificity | 2 | 2020 | 1998 | 0.040 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 1 | 2021 | 109 | 0.040 |
Why?
| | Communicable Disease Control | 1 | 2021 | 88 | 0.040 |
Why?
| | Receptors, Immunologic | 1 | 2021 | 210 | 0.040 |
Why?
| | Membrane Proteins | 2 | 2018 | 1130 | 0.040 |
Why?
| | Major Histocompatibility Complex | 1 | 2021 | 234 | 0.040 |
Why?
| | Consensus | 1 | 2022 | 467 | 0.040 |
Why?
| | Pituitary-Adrenal System | 1 | 2021 | 169 | 0.040 |
Why?
| | Policy | 1 | 2021 | 147 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2021 | 496 | 0.040 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2021 | 204 | 0.040 |
Why?
| | Pharmacovigilance | 1 | 2019 | 25 | 0.040 |
Why?
| | Genome | 1 | 2022 | 307 | 0.040 |
Why?
| | Polyesters | 1 | 2020 | 76 | 0.040 |
Why?
| | Chromosomes, Human, X | 1 | 2019 | 76 | 0.040 |
Why?
| | False Positive Reactions | 1 | 2019 | 124 | 0.040 |
Why?
| | Chromosomes, Human, Pair 11 | 1 | 2019 | 61 | 0.040 |
Why?
| | Waist Circumference | 1 | 2020 | 142 | 0.040 |
Why?
| | Remission Induction | 1 | 2020 | 308 | 0.040 |
Why?
| | Hydrocortisone | 1 | 2021 | 303 | 0.040 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2019 | 82 | 0.040 |
Why?
| | Cohort Effect | 1 | 2019 | 5 | 0.040 |
Why?
| | Oxygen | 2 | 2018 | 997 | 0.040 |
Why?
| | Neurons | 2 | 2018 | 1668 | 0.040 |
Why?
| | Microglia | 1 | 2022 | 289 | 0.040 |
Why?
| | Chromosome Duplication | 1 | 2018 | 6 | 0.040 |
Why?
| | Medical Records Systems, Computerized | 1 | 2019 | 95 | 0.040 |
Why?
| | Ear | 1 | 2019 | 31 | 0.040 |
Why?
| | Infant, Newborn | 2 | 2022 | 6460 | 0.040 |
Why?
| | Nucleus Accumbens | 1 | 2020 | 135 | 0.040 |
Why?
| | Granulocytes | 1 | 2018 | 82 | 0.040 |
Why?
| | Molecular Sequence Annotation | 1 | 2019 | 110 | 0.040 |
Why?
| | Cholesterol | 1 | 2021 | 411 | 0.040 |
Why?
| | Organ Specificity | 1 | 2019 | 307 | 0.040 |
Why?
| | Telomere | 1 | 2022 | 300 | 0.040 |
Why?
| | Computer Simulation | 1 | 2023 | 1014 | 0.030 |
Why?
| | Chronic Disease | 1 | 2025 | 1827 | 0.030 |
Why?
| | Lymphocyte Count | 1 | 2018 | 167 | 0.030 |
Why?
| | Systems Biology | 1 | 2019 | 68 | 0.030 |
Why?
| | Community Health Planning | 1 | 2018 | 38 | 0.030 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2018 | 46 | 0.030 |
Why?
| | Plasma Cells | 1 | 2018 | 80 | 0.030 |
Why?
| | Hydrolases | 1 | 2018 | 42 | 0.030 |
Why?
| | F-Box Proteins | 1 | 2018 | 24 | 0.030 |
Why?
| | Death | 1 | 2019 | 129 | 0.030 |
Why?
| | Tobacco Use Disorder | 1 | 2020 | 217 | 0.030 |
Why?
| | Genetic Testing | 1 | 2021 | 492 | 0.030 |
Why?
| | Statistics as Topic | 2 | 2009 | 279 | 0.030 |
Why?
| | Brain Chemistry | 1 | 2018 | 122 | 0.030 |
Why?
| | Event-Related Potentials, P300 | 1 | 2017 | 17 | 0.030 |
Why?
| | Dominance, Cerebral | 2 | 2007 | 57 | 0.030 |
Why?
| | Conditioning, Classical | 1 | 2018 | 120 | 0.030 |
Why?
| | Berlin | 1 | 2017 | 2 | 0.030 |
Why?
| | Cation Transport Proteins | 1 | 2018 | 120 | 0.030 |
Why?
| | Cell Adhesion Molecules | 1 | 2018 | 180 | 0.030 |
Why?
| | Neurogenesis | 1 | 2019 | 158 | 0.030 |
Why?
| | Microtubule-Associated Proteins | 1 | 2018 | 187 | 0.030 |
Why?
| | Calcium-Binding Proteins | 1 | 2018 | 221 | 0.030 |
Why?
| | Acid Anhydride Hydrolases | 1 | 2016 | 8 | 0.030 |
Why?
| | Genotyping Techniques | 1 | 2017 | 74 | 0.030 |
Why?
| | United States | 2 | 2025 | 16136 | 0.030 |
Why?
| | Nonlinear Dynamics | 1 | 2017 | 96 | 0.030 |
Why?
| | Suicidal Ideation | 1 | 2022 | 543 | 0.030 |
Why?
| | Abnormalities, Multiple | 1 | 2018 | 195 | 0.030 |
Why?
| | Oncogene Protein v-akt | 1 | 2016 | 24 | 0.030 |
Why?
| | Transcription Factor 4 | 1 | 2016 | 2 | 0.030 |
Why?
| | Models, Animal | 1 | 2018 | 387 | 0.030 |
Why?
| | Prognosis | 2 | 2016 | 4351 | 0.030 |
Why?
| | Verbal Learning | 2 | 2007 | 75 | 0.030 |
Why?
| | Time Factors | 2 | 2020 | 7109 | 0.030 |
Why?
| | Organoids | 1 | 2018 | 143 | 0.030 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2018 | 198 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2017 | 426 | 0.030 |
Why?
| | Denmark | 1 | 2016 | 51 | 0.030 |
Why?
| | Diseases in Twins | 1 | 2017 | 115 | 0.030 |
Why?
| | Fanconi Anemia Complementation Group Proteins | 1 | 2016 | 7 | 0.030 |
Why?
| | Adaptation, Psychological | 1 | 2021 | 721 | 0.030 |
Why?
| | Cognitive Aging | 1 | 2016 | 19 | 0.030 |
Why?
| | Atherosclerosis | 1 | 2020 | 410 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 441 | 0.030 |
Why?
| | Twins | 1 | 2017 | 156 | 0.030 |
Why?
| | Uric Acid | 1 | 2017 | 167 | 0.030 |
Why?
| | Football | 1 | 2017 | 90 | 0.030 |
Why?
| | Congresses as Topic | 1 | 2017 | 226 | 0.030 |
Why?
| | Cerebellum | 2 | 2007 | 225 | 0.030 |
Why?
| | Motivation | 1 | 2020 | 605 | 0.030 |
Why?
| | Psychological Tests | 1 | 2016 | 127 | 0.030 |
Why?
| | Sports Medicine | 1 | 2017 | 120 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2019 | 1543 | 0.030 |
Why?
| | Psychotropic Drugs | 1 | 2016 | 75 | 0.030 |
Why?
| | Fasting | 1 | 2017 | 280 | 0.030 |
Why?
| | Ethanol | 1 | 2020 | 630 | 0.030 |
Why?
| | Terminology as Topic | 1 | 2017 | 253 | 0.030 |
Why?
| | Putamen | 1 | 2015 | 23 | 0.030 |
Why?
| | Executive Function | 1 | 2019 | 463 | 0.030 |
Why?
| | Body Weight | 1 | 2019 | 968 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2021 | 876 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 2017 | 771 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2016 | 384 | 0.030 |
Why?
| | Pain Measurement | 1 | 2017 | 573 | 0.030 |
Why?
| | Stem Cells | 1 | 2018 | 613 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1707 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 2016 | 444 | 0.020 |
Why?
| | Genetic Heterogeneity | 1 | 2013 | 67 | 0.020 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2013 | 64 | 0.020 |
Why?
| | Heart Rate | 1 | 2017 | 846 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2018 | 740 | 0.020 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2018 | 931 | 0.020 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2018 | 1150 | 0.020 |
Why?
| | Publication Bias | 1 | 2011 | 19 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2018 | 2502 | 0.020 |
Why?
| | Cooperative Behavior | 1 | 2014 | 471 | 0.020 |
Why?
| | Alcohol-Induced Disorders, Nervous System | 1 | 2010 | 7 | 0.020 |
Why?
| | Parkinson Disease | 1 | 2016 | 614 | 0.020 |
Why?
| | Crohn Disease | 1 | 2013 | 250 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2015 | 902 | 0.020 |
Why?
| | Calibration | 1 | 2009 | 154 | 0.020 |
Why?
| | Veterans | 1 | 2021 | 1650 | 0.020 |
Why?
| | Electronic Health Records | 1 | 2017 | 1210 | 0.020 |
Why?
| | Word Association Tests | 1 | 2007 | 3 | 0.020 |
Why?
| | Image Enhancement | 1 | 2009 | 198 | 0.020 |
Why?
| | Reference Values | 1 | 2009 | 796 | 0.020 |
Why?
| | Parietal Lobe | 1 | 2007 | 62 | 0.020 |
Why?
| | Asthma | 1 | 2019 | 1800 | 0.020 |
Why?
| | Corpus Callosum | 1 | 2007 | 76 | 0.020 |
Why?
| | Thalamic Nuclei | 1 | 2006 | 10 | 0.020 |
Why?
| | Culture | 1 | 2007 | 122 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2016 | 5439 | 0.020 |
Why?
| | Blood Glucose | 1 | 2017 | 2360 | 0.020 |
Why?
| | Obesity | 1 | 2020 | 3131 | 0.010 |
Why?
| | Frontal Lobe | 1 | 2007 | 159 | 0.010 |
Why?
| | Quality of Life | 1 | 2019 | 3200 | 0.010 |
Why?
| | Apoptosis | 1 | 2015 | 2439 | 0.010 |
Why?
| | Mental Recall | 1 | 2007 | 226 | 0.010 |
Why?
| | Infant | 1 | 2019 | 10114 | 0.010 |
Why?
| | Psychomotor Performance | 1 | 2007 | 329 | 0.010 |
Why?
| | Psychometrics | 1 | 2007 | 712 | 0.010 |
Why?
|
|
McIntosh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|